BlueRock Therapeutics – I was very excited but indeed intimidated when I first joined but with the support of my team and manager, I slowly started to finding my feet. Now with the intimidation gone, the excitement remains and I am thrilled to be a member of this team working on products that impact patients' lives
BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.
Weiterlesen
Dieses Unternehmen nimmt Feedback von überprüften Mitarbeitern entgegen
I was very excited but indeed intimidated when I first joined but with the support of my team and manager, I slowly started to finding my feet. Now with the intimidation gone, the excitement remains and I am thrilled to be a member of this team working on products that impact patients' lives
Was sind einige der besten Dinge an Ihrem Team?
Open communication and collective dedication to collaboration.
Was gefällt dir am besten am Führungsteam?
Openness, and willingness to foster employee personal growth
Was ist das Beste an Ihrem Vergütungspaket?
Health insurance and Group pension plan
Was ist am positivsten an Kultur und Umgang in Ihrem Unternehmen?
The inviting and engaging office space and work environment in general.
Was macht Sie bei der Arbeit am glücklichsten?
Being a member of a team working on a product/products that changes people's life is a lifelong dream of mine! It is becoming a reality at BRT.